Pharma News, 2020

The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive.

PerkinElmer has moved to expand its life sciences portfolio with CRISPR and gene editing offerings by snapping up the cell engineering specialist Horizon Discovery.

Lung cancer diagnosis and treatment are tough enough in the best of times.

Sanofi has entered into a deal to buy Kiadis, a clinical-stage biopharmaceutical company developing innovative ‘off the shelf’ natural killer (NK) cell based medicines for the treatment of...

The duo explained that the AI model’s natural language processing allowed them to pick up subtleties and changes in speech that they may have otherwise been missed.

New Delhi.

Dr.

AstraZeneca is divesting two cardiovascular drugs to Germany’s Cheplapharm Arzneimittel GmbH for $400 million, which will allow the UK pharma giant to reinvest in its main therapy areas.

GENEVA (Reuters) - A group of World Health Organization (WHO) experts held a virtual meeting with Chinese counterparts on Friday to discuss the coronavirus pandemic, WHO chief Tedros A...

Bristol Myers Squibb has signed a five-year collaboration agreement with machine learning specialist insitro to develop drugs for amyotrophic lateral sclerosis (ALS) and frontotemporal dementi...

Sanofi is partnering with Merck to test its THOR-707 compound with Merck’s checkpoint inhibitor Keytruda (pembrolizumab) in solid tumors.

Gilead Sciences reported stronger-than-expected third-quarter earnings on Wednesday as sales of its coronavirus treatment remdesivir touted by President Donald Trump drove revenue up by 17% from l...